Scotia Capital’s QUESTCOR PHARMA INC QCOR Stock Holding History

Scotia Capital’s Portfolio QCOR Stock Details QCOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-4,683	Closed	-$272K	–	580
2013 Q3	$272K	Buy	+4,683	New	+$278K	0.01%	419

Other funds holding QCOR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

TCIM

TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Scotia Capital's QCOR Position: Q4 2013 in Review

Scotia Capital sold out of QUESTCOR PHARMA INC (QCOR) in Q4 2013, closing a stake of 4,683 shares — an estimated $272K sold.

Scotia Capital first reported a position in QCOR in Q3 2013 and held it in 1 quarter. The position peaked at $272K in Q3 2013. 285 funds tracked by Wall St. Rank hold QCOR as of Q4 2013.

Scotia Capital reported no remaining QUESTCOR PHARMA INC position as of Q4 2013 after selling out during the quarter.
Scotia Capital sold 4,683 QUESTCOR PHARMA INC shares in Q4 2013, an estimated $272K.
Scotia Capital first reported a position in QUESTCOR PHARMA INC in Q3 2013 and held it in 1 quarter.
Scotia Capital's QUESTCOR PHARMA INC position peaked at $272K in Q3 2013.
285 funds tracked by Wall St. Rank held QUESTCOR PHARMA INC as of Q4 2013.

Based on Scotia Capital's 13F filing for Q4 2013, filed 14 Feb 2014.